For innovation to be successful it must be developed in collaboration with those set to use or benefit from it.
Involvement and co-production with people, public, carers, and communities is a growing and thriving agenda across the AHSN Network, and is even more important than it has ever been, given the experiences of the COVID-19 pandemic.
With this in mind, during 2020/2021 the Network reviewed activity across AHSNs to support a more strategic approach to involvement and co-production of innovation and developed its co-production strategy.
Read more about our approach to co-production and patient and public involvement.
“Health equity is the attainment of the highest level of health for ALL people. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and social determinants of health — and to eliminate disparities in health and health care.” (health.gov) Within the NHS there [...]
Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red blood cells that can cause problems because they do not live as long as healthy blood cells and can block blood vessels. This can result in suffers experiencing painful episodes, called sickle cell crises, as well as anaemia, [...]
At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made across the system to better support some of our most under-served communities. To maintain this momentum, we must not just embed tackling health and healthcare inequalities in all that we do, [...]
